Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2024-08-07

What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2024-08-07 (fiscal Q2 2024): 46 published measures, 129 facts as tagged in accession 0001161697-24-000334.

This filing

Form
10-Q (quarterly report)
Filed
2024-08-07
Fiscal period
fiscal Q2 2024
Accession
0001161697-24-000334 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-3027,303,566USD
At 2023-12-3128,460,972USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-308,599,016USD
At 2023-12-318,107,201USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-06-3018,704,550USD
At 2024-03-3119,117,531USD
At 2023-12-3120,353,771USD
At 2023-06-3028,101,147USD
At 2023-03-3129,796,300USD
At 2022-12-3131,325,963USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-06-3010,458,001USD
At 2023-12-3111,482,240USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-988,715USD91
2024-01-01 to 2024-06-30-2,924,673USD182
2024-01-01 to 2024-03-31-1,935,958USD91
2023-04-01 to 2023-06-30-2,495,886USD91
2023-01-01 to 2023-06-30-4,906,771USD181
2023-01-01 to 2023-03-31-2,410,885USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-335,385USD182
2023-01-01 to 2023-06-30-4,814,520USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-04-01 to 2024-06-308,430,089USD91
2024-01-01 to 2024-06-3016,627,887USD182
2023-04-01 to 2023-06-306,935,931USD91
2023-01-01 to 2023-06-3014,328,536USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-407,271USD182
2023-01-01 to 2023-06-30-481,788USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-281,583USD182
2023-01-01 to 2023-06-30-392,544USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-26,236,946USD
At 2023-12-31-23,312,273USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-3045,811,373shares91
2024-01-01 to 2024-06-3045,761,799shares182
2023-04-01 to 2023-06-3045,606,603shares91
2023-01-01 to 2023-06-3045,547,427shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-3045,811,373shares91
2024-01-01 to 2024-06-3045,761,799shares182
2023-04-01 to 2023-06-3045,606,603shares91
2023-01-01 to 2023-06-3045,547,427shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.02USD/shares91
2024-01-01 to 2024-06-30-0.06USD/shares182
2023-04-01 to 2023-06-30-0.05USD/shares91
2023-01-01 to 2023-06-30-0.11USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.02USD/shares91
2024-01-01 to 2024-06-30-0.06USD/shares182
2023-04-01 to 2023-06-30-0.05USD/shares91
2023-01-01 to 2023-06-30-0.11USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-599,995USD91
2023-01-01 to 2023-06-30-1,177,395USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-06-303,678,984USD
At 2023-12-313,837,657USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-06-301,314,384USD182
2023-01-01 to 2023-06-301,681,955USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-1,192,034USD91
2024-01-01 to 2024-06-30-3,153,400USD182
2023-04-01 to 2023-06-30-3,224,576USD91
2023-01-01 to 2023-06-30-6,281,404USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-3019,365,697USD
At 2023-12-3120,255,929USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-305,136,840USD
At 2023-12-314,454,278USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-06-301,595,691USD
At 2023-12-31975,193USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2024-06-30745,084USD
At 2023-12-31754,361USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-06-305,846,082USD
At 2023-12-314,045,211USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-306,671,784USD91
2024-01-01 to 2024-06-3013,736,448USD182
2023-04-01 to 2023-06-307,112,700USD91
2023-01-01 to 2023-06-3014,316,563USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2024-06-302,588,750USD
At 2023-12-313,481,301USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-305,479,750USD91
2024-01-01 to 2024-06-3010,583,048USD182
2023-04-01 to 2023-06-303,888,124USD91
2023-01-01 to 2023-06-308,035,159USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2024-04-01 to 2024-06-305,319,688USD91
2024-01-01 to 2024-06-3010,677,308USD182
2023-04-01 to 2023-06-305,303,167USD91
2023-01-01 to 2023-06-3010,729,044USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,134,232USD91
2024-01-01 to 2024-06-302,609,907USD182
2023-04-01 to 2023-06-301,596,614USD91
2023-01-01 to 2023-06-303,161,483USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3045,819,286shares
At 2023-12-3145,669,362shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-06-303,414,831USD
At 2023-12-313,514,055USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-06-303,594,396USD
At 2023-12-313,704,613USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2024-06-306,812,865USD
At 2023-12-316,558,930USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-06-303,133,881USD
At 2023-12-312,721,273USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-06-3098,970USD
At 2023-12-3198,970USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-06-302,144,722USD
At 2023-12-311,711,427USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-04-01 to 2024-06-30217,864USD91
2024-01-01 to 2024-06-30449,233USD182
2023-04-01 to 2023-06-30212,919USD91
2023-01-01 to 2023-06-30426,036USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2024-04-01 to 2024-06-30217,864USD91
2024-01-01 to 2024-06-30449,233USD182
2023-04-01 to 2023-06-30212,919USD91
2023-01-01 to 2023-06-30426,036USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-04-01 to 2024-06-30213,999USD91
2024-01-01 to 2024-06-30251,186USD182
2023-04-01 to 2023-06-30131,167USD91
2023-01-01 to 2023-06-30256,669USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-04-01 to 2024-06-30203,319USD91
2024-01-01 to 2024-06-30228,727USD182
2023-04-01 to 2023-06-30128,695USD91
2023-01-01 to 2023-06-30197,238USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2024-04-01 to 2024-06-300USD91
2024-01-01 to 2024-06-300USD182
2023-04-01 to 2023-06-30599,995USD91
2023-01-01 to 2023-06-301,177,395USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-01-01 to 2024-06-3020,491USD182
2023-01-01 to 2023-06-3020,165USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2023-01-01 to 2023-06-303,160USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2024-01-01 to 2024-06-30244,879USD182
2023-01-01 to 2023-06-30229,879USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-301,800,871USD182
2023-01-01 to 2023-06-30239,590USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-892,551USD182
2023-01-01 to 2023-06-30-1,126,643USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30620,498USD182
2023-01-01 to 2023-06-30-817,169USD181

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
2026-09-19T14:58:00.731Z
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))